A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...

11 analysts have shared their evaluations of Insulet PODD during the recent three months, expressing a mix of bullish and ...

Citi Research analysts updated their “SMID value creators” list, removing Globant . The “SMID Value Creators List” names buy-rated stocks by Citi analysts ...

OTR Global has a Positive read on Tandem Diabetes (TNDM) and Insulet (PODD) after interviews with U.S. endocrinology practitioners that showed ...